Literature DB >> 8534860

The influence of angiogenesis research on management of patients with breast cancer.

J Folkman1.   

Abstract

The diagnosis and treatment of patients with breast cancer is beginning to be influenced by new ideas and discoveries emerging from the field of angiogenesis research. This field, pursued in the laboratory for more than 20 years, has in the past 5 years generated clinical applications. Some of these applications have begun to change current thinking about cancer patients and especially about those with breast cancer. I here discuss how an understanding of the process of angiogenesis may contribute to improved management of patients with breast cancer.

Entities:  

Mesh：

Year:  1995        PMID： 8534860     DOI： 10.1007/bf00666033

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


  69 in total

Review 1.  The inhibition of tumor growth by tumor mass.

Authors:  R T Prehn
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

2.  Ultrastructural autoradiographic studies of the early vasoproliferative response in tumor angiogenesis.

Authors:  T Cavallo; R Sade; J Folkman; R S Cotran
Journal:  Am J Pathol       Date:  1973-03       Impact factor: 4.307

3.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

4.  Angiogenesis in vitro.

Authors:  J Folkman; C Haudenschild
Journal:  Nature       Date:  1980-12-11       Impact factor: 49.962

Review 5.  Dormancy and breast cancer.

Authors:  A Meltzer
Journal:  J Surg Oncol       Date:  1990-03       Impact factor: 3.454

6.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

7.  Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.

Authors:  M S Pepper; N Ferrara; L Orci; R Montesano
Journal:  Biochem Biophys Res Commun       Date:  1992-12-15       Impact factor: 3.575

8.  Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

Authors:  H F Dvorak; J A Nagy; J T Dvorak; A M Dvorak
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

9.  Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.

Authors:  P C Brooks; A M Montgomery; M Rosenfeld; R A Reisfeld; T Hu; G Klier; D A Cheresh
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

10.  [Tumor vascular invasion in breast carcinoma. Hematoxylin-eosin versus immunohistochemical staining for factor VIII antigen].

Authors:  A Obermair; K Czerwenka; C Kurz; A Kaider; P Sevelda
Journal:  Dtsch Med Wochenschr       Date:  1994-11-04       Impact factor: 0.628
View more
  14 in total

Review 1.  A role for antiangiogenic therapy in breast cancer.

Authors:  Marsha A Moses; Jay Harper; Cecilia A Fernández
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

Review 2.  Multiscale imaging and computational modeling of blood flow in the tumor vasculature.

Authors:  Eugene Kim; Spyros Stamatelos; Jana Cebulla; Zaver M Bhujwalla; Aleksander S Popel; Arvind P Pathak
Journal:  Ann Biomed Eng       Date:  2012-05-08       Impact factor: 3.934

3.  Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas.

Authors:  Leandro E Mainetti; Viviana R Rozados; Ana Rossa; R Daniel Bonfil; O Graciela Scharovsky
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-27       Impact factor: 4.553

Review 4.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

5.  Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer.

Authors:  Angela M Jarrett; Meghan J Bloom; Wesley Godfrey; Anum K Syed; David A Ekrut; Lauren I Ehrlich; Thomas E Yankeelov; Anna G Sorace
Journal:  Math Med Biol       Date:  2019-09-02       Impact factor: 1.854

6.  Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.

Authors:  Marco Colleoni; Kathryn P Gray; Shari Gelber; István Láng; Beat Thürlimann; Lorenzo Gianni; Ehtesham A Abdi; Henry L Gomez; Barbro K Linderholm; Fabio Puglisi; Carlo Tondini; Elena Kralidis; Alexandru Eniu; Katia Cagossi; Daniel Rauch; Jacquie Chirgwin; Richard D Gelber; Meredith M Regan; Alan S Coates; Karen N Price; Giuseppe Viale; Aron Goldhirsch
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

7.  Design, synthesis and evaluation of 2-amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors and antiangiogenic agents.

Authors:  Aleem Gangjee; Ying Zhao; Sudhir Raghavan; Michael A Ihnat; Bryan C Disch
Journal:  Bioorg Med Chem       Date:  2010-05-25       Impact factor: 3.641

8.  Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene.

Authors:  Xiao-Guang Lu; Li-Bin Zhan; Bing-An Feng; Ming-Yang Qu; Li-Hua Yu; Ji-Hong Xie
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

9.  The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents.

Authors:  Xin Zhang; Sudhir Raghavan; Michael Ihnat; Jessica E Thorpe; Bryan C Disch; Anja Bastian; Lora C Bailey-Downs; Nicholas F Dybdal-Hargreaves; Cristina C Rohena; Ernest Hamel; Susan L Mooberry; Aleem Gangjee
Journal:  Bioorg Med Chem       Date:  2014-05-14       Impact factor: 3.641

10.  Angiogenesis in Endocrine Neoplasms.

Authors:  Martin Jugenburg; Kalman Kovacs; Ivan Jugenburg; Bernd W. Scheithauer
Journal:  Endocr Pathol       Date:  1997       Impact factor: 4.056
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.